Manufacturer copay assistance · Ziextenzo (Q5120) · Sandoz
Eligible patients pay $0… · Maximum benefit $0 copay for eligible commercially insured patients · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Ziextenzo — check the full fund board.
Run a benefits estimate for Ziextenzo — the program's cap applies against the patient share CareCost calculates.
Yes — Sandoz One Source Co-Pay Program from Sandoz. Eligible patients pay $0 copay. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay $0 copay Maximum benefit: $0 copay for eligible commercially insured patients. Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.